Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (FY)Dec 31, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 24.22B | 3.83%101.46B | 2.00%23.92B | 5.93%22.69B | 9.72%97.71B | 30.13B | 8.84%22.71B | 14.30%23.45B | 12.18%21.42B | 11.76%89.06B |
| Cost of revenue | 18.38B | 3.99%75.86B | 1.48%17.79B | 5.44%16.93B | 8.26%72.95B | 22.27B | 7.95%17.09B | 12.08%17.53B | 10.41%16.06B | 11.04%67.38B |
| Gross profit | 5.84B | 3.38%25.6B | 3.55%6.13B | 7.39%5.77B | 14.25%24.77B | 7.86B | 11.61%5.62B | 21.45%5.92B | 17.82%5.37B | 14.05%21.68B |
| Operating expense | 4.43B | 3.36%17.59B | -3.32%4.22B | 5.18%4.15B | 8.38%17.02B | 4.62B | 7.60%4.09B | 16.80%4.37B | 8.15%3.94B | 5.67%15.71B |
| Staff costs | --1.41B | ---- | -4.71%1.44B | 4.83%1.37B | ---- | ---- | 13.17%1.37B | 17.71%1.51B | 6.70%1.31B | ---- |
| Selling and administrative expenses | --988M | ---- | -1.95%1.01B | -3.38%942M | ---- | ---- | -2.99%942M | 5.66%1.03B | 8.70%975M | ---- |
| -General and administrative expense | --988M | ---- | -1.95%1.01B | -3.38%942M | ---- | ---- | -2.99%942M | 5.66%1.03B | 8.70%975M | ---- |
| Depreciation and amortization | --195M | ---- | -35.51%89M | -16.10%99M | ---- | ---- | 2.88%107M | 53.33%138M | 31.11%118M | ---- |
| -Depreciation | --195M | ---- | -35.51%89M | -16.10%99M | ---- | ---- | 2.88%107M | 53.33%138M | 31.11%118M | ---- |
| Rent and land expenses | --846M | ---- | -2.28%727M | -0.27%733M | ---- | ---- | 9.71%768M | 7.67%744M | 10.69%735M | ---- |
| Other operating expenses | --989M | ---- | 1.26%962M | 24.10%1B | ---- | ---- | 10.72%909M | 34.75%950M | 4.93%809M | ---- |
| Operating profit | 1.42B | 3.43%8.01B | 22.83%1.91B | 13.52%1.62B | 29.67%7.74B | 3.24B | 24.00%1.52B | 36.76%1.56B | 56.47%1.43B | 44.08%5.97B |
| Net non-operating interest income (expenses) | 30M | -17.45%123M | -14.71%29M | -23.08%30M | 17.32%149M | 34M | 35.48%42M | -12.82%34M | 77.27%39M | 18.69%127M |
| Non-operating interest income | --32M | -16.00%126M | -14.29%30M | -23.08%30M | 17.19%150M | --33M | 34.38%43M | -10.26%35M | 77.27%39M | 18.52%128M |
| Non-operating interest expense | --2M | 200.00%3M | 0.00%1M | --0 | 0.00%1M | ---1M | 0.00%1M | --1M | --0 | 0.00%1M |
| Net investment income | 20M | -0.87%114M | -15.69%43M | -35.00%13M | -10.16%115M | 42M | -90.48%2M | -23.88%51M | 122.22%20M | 12.28%128M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 10,750.00%852M | 171M | 8,600.00%510M | 87.50%-8M | 0 | 95.35%-2M | 0 | 71.43%-6M | -392.31%-64M |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -1M | 118.85%23M | 400.00%45M | -100.00%-6M | 67.12%-122M | -80M | -60.00%-24M | 92.02%-15M | 40.00%-3M | -75.00%-371M |
| Less:Other special charges | --1M | -118.85%-23M | -400.00%-45M | 100.00%6M | 154.17%122M | --80M | 60.00%24M | --15M | -40.00%3M | -53.85%48M |
| Less:Write off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 199.07%323M |
| Other non-operating income (expenses) | 19M | -37.10%39M | -33.33%10M | -23.53%13M | -54.41%62M | 15M | -6.25%15M | -11.76%15M | -82.65%17M | 88.89%136M |
| Income before tax | 1.48B | 15.35%9.16B | 34.51%2.21B | 46.07%2.18B | 34.03%7.94B | 3.26B | 25.81%1.56B | 56.64%1.64B | 46.99%1.49B | 40.60%5.93B |
| Income tax | 465M | 24.30%2.84B | 35.31%686M | 42.42%695M | 22.03%2.29B | 809M | 18.05%484M | 48.25%507M | 65.42%488M | 33.83%1.88B |
| Net income | 1.02B | 11.75%6.32B | 34.28%1.52B | 47.75%1.48B | 39.56%5.65B | 2.45B | 29.78%1.07B | 60.57%1.13B | 39.61%1B | 43.97%4.05B |
| Net income continuous operations | --1.02B | 11.73%6.32B | 34.16%1.52B | 47.85%1.48B | 39.58%5.65B | --2.45B | 29.66%1.07B | 60.71%1.13B | 39.42%1B | 43.97%4.05B |
| Noncontrolling interests | 0 | 0 | 27.27%-8M | |||||||
| Net income attributable to the company | 1.02B | 11.75%6.32B | 34.28%1.52B | 47.75%1.48B | 39.28%5.65B | 2.45B | 29.47%1.07B | 60.57%1.13B | 39.61%1B | 43.70%4.06B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 1.02B | 11.75%6.32B | 34.28%1.52B | 47.75%1.48B | 39.28%5.65B | 2.45B | 29.47%1.07B | 60.57%1.13B | 39.61%1B | 43.70%4.06B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 18.04 | 12.27%111.1733 | 34.38%26.66 | 47.61%25.9 | 39.11%99.0233 | 42.87 | 29.19%18.7667 | 60.56%19.84 | 39.33%17.5467 | 43.60%71.1833 |
| Diluted earnings per share | 18.04 | 12.29%111.1133 | 34.41%26.65 | 47.60%25.88 | 39.12%98.9533 | 42.84 | 29.18%18.7533 | 60.63%19.8267 | 39.34%17.5333 | 43.66%71.1267 |
| Dividend per share | 0 | 31.11%39.3333 | 48.57%17.3333 | 0 | 38.46%30 | 18.3333 | 0 | 16.67%11.6667 | 0 | 30.00%21.6667 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |